Virbac SA is a French pharmaceutical company exclusively dedicated to animal health, founded in 1968 by veterinarian Pierre-Richard Dick. It manufactures and markets a comprehensive portfolio of products including vaccines, antibiotics, parasiticides, anti-inflammatory drugs, dermatology solutions, dental care, diagnostics, nutrition, pet food, and specialty pharmaceuticals for companion animals and food-producing livestock. Serving veterinarians, farmers, and pet owners, Virbac operates in over 100 countries across Europe, North America, Latin America, East Asia, India, Africa, the Middle East, and the Pacific, with the majority of revenue generated in Europe. The company maintains production facilities in 10 countries, such as France, the US, Mexico, Brazil, and Vietnam, and employs over 5,600 people worldwide. Headquartered in Carros, France, Virbac emphasizes research and development through dedicated centers, fostering innovation in biological and pharmaceutical products. As the world's sixth-largest veterinary biopharma group, family-controlled with majority voting rights retained by the founder's family, it upholds independence and a commitment to sustainable animal health solutions.